OGT 918 100 (Zavesca 100 mg)
Generic Name: miglustat
Pill imprint OGT 918 100 has been identified as Zavesca 100 mg.
Zavesca is used in the treatment of gaucher disease and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Zavesca 100 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 100 mg
- 14.00 mm
- Prescription only
More about Zavesca (miglustat)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.